Great report thx and raised new points for me e.g. "the patient...

First 3 Last

Share
Profile

Follow
MADX

488 Posts.

34

21/03/19

20:27

Post #: 37844799
Share

Originally posted by stocking: ↑

Attended Kate's presentation today and here are my thoughts for what they are worth:

- Kate was an extremely professional and knowledgeable speaker; it's great to see this kind of experience in a company with a MC that is ALC speaking confidently about successes to date and the opportunity.
- The market is genuine, tangible and here right now; it will only grow.
- ALC is not trying to be everything to everyone; they are solving simple problems for partners and then expanding (see the slide with the whiteboard > dashboard view). They are also happy to partner with 3rd parties to enable new capabilities.
- ALC has 100+ employees; the acq of MKM was a very good play by management, as they have the on the ground practical experience to implement the solution.
- Miya Precision has substantial upside as a product in isolation - it would be good to learn more about the practical feedback from the Palmerston site, I think this would be good investor info for ALC to focus on to better understand the leverage they have once implemented.
- ALC is genuinely only getting started; the opportunity to leverage the AI capability is only the tip of the iceberg, the patient data at scale could make ALC a highly regarded research platform for major medical / pharma players.
- ALC's solutions are sticky; this is not a fly by night engagement with hospitals, but will drive significant recurring revenue growth.
- A large chunk of the top 20 have a vested interest for the longer term (MKM vendors, key management)

I believe ALC has some exciting years ahead, but I also believe it will likely get taken out sooner (say 12-24 months) rather than later by a bigger player as the story gets out and potential realised.

Price wise, this could easily trade on 10x revenue, and at this stage likely 0.14-0.16c range (crude calculation on current MC and $14M revenue realised this year ex pipeline). Being a realist however, I do think there will be a CR at some point given $1.5M in the kitty and a favourable price rise.

Expand

Great report thx and raised new points for me e.g. "the patient data at scale could make ALC a highly regarded research platform for major medical / pharma players. "

ALC Price at posting: 5.7¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

There are more pages in this discussion • 29 more messages in this thread...

First 3 Last

Add ALC (ASX) to my watchlist

(20min delay)
Last 6.4¢		Change -0.002(3.03%)		Mkt cap ! $72.51M

Open	High	Low	Value	Volume
6.8¢	6.8¢	6.1¢	$78.67K	1.235M

Buyers (Bids)

No.	Vol.	Price($)
1	29679	6.3¢

Sellers (Offers)

Price($)	Vol.	No.
6.4¢	314246	1

View Market Depth

No.	Vol.	Price($)
1	256518	0.065
2	539747	0.064
1	200	0.063
1	10000	0.062
2	149000	0.061

Price($)	Vol.	No.
0.066	128118	1
0.068	232449	1
0.069	50000	1
0.070	160606	2
0.071	20177	1

Last trade - 15.59pm 22/11/2024 (20 minute delay)

ALC (ASX) Chart

Great report thx and raised new points for me e.g. "the patient...

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Scientific conference spotlights PYC's work on blindness disease treatment

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Sales growth pushes Lovisa's fortunes (and shares) upwards

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

Buyers (Bids)

Sellers (Offers)